Extracellular vesicles (EVs) are important means of intercellular communication and a potent tool for regenerative therapy. In ischemic stroke, transient blockage of a brain artery leads to a lack of glucose and oxygen in the affected brain tissue, provoking neuronal death by necrosis in the core of the ischemic region. The fate of neurons in the surrounding penumbra depends on the stimuli, including EVs, received during the following hours. A detailed characterization of such stimuli is crucial not only for understanding stroke pathophysiology but also for new therapeutic interventions.
INTRODUCTION
Extracellular vesicles (EVs) are lipid bilayer structures released from almost all types of cells, that carry biologically active molecules, such as proteins, lipids, and extracellular RNAs (e.g. mRNA, miRNA, tRNA and YRNA), and are capable to elicit responses in the receptor cells 1, 2 .
Although once considered as "platelet dust" or "trash cans", EVs are currently regarded as potent means of intercellular communication and currently represent an intense field of research [3] [4] [5] [6] . Exosomes (with a size of 40-150 nm, originating from multivesicular bodies), microvesicles (150-1,000 nm, shed from the plasma membrane) and apoptotic vesicles (ApoEVs; 1,000-5,000 nm, released from cells undergoing apoptosis) are subtypes of EVs. An increasing amount of evidence shows that EVs play important roles in physiological and in pathological conditions [7] [8] [9] . Moreover, they are considered as potential disease biomarkers and, given their ability to cross the blood-brain barrier (BBB), are also investigated as tools for tissue-or cell-specific delivery of a therapeutic cargo [10] [11] [12] [13] [14] .
Stroke is the second most common cause of death and the main cause of disability worldwide, being responsible for ~6 million deaths in 2016 (http://www.who.int/en/news-room/factsheets/detail/the-top-10-causes-of-death). Ischemic stroke accounts for 87% of cases and is caused by an occluded brain artery, which leads to a temporary lack of glucose and oxygen supply in the affected brain region. Neurons -the most susceptible brain cell population-that are at the core of the stroke will die by necrosis, whereas neurons located at the periphery (penumbra) will enter into electrical silence and, depending on many factors, will either die or survive 15, 16 . The pathophysiology of stroke is very complex and involves several mechanisms such as excitotoxicity and neuroinflammation [17] [18] [19] . At present, the only therapeutic approach is recanalization and treatment with recombinant tissue plasminogen activator (rtPA). The latter has a very limited time window of 4.5 to 6 hours after stroke and, thus, only 20% of the stroke patients can benefit from it 20 . Hence, there is an urgent need for novel therapeutic options to be used after this time period. At present, EVs are regarded as therapeutic tools for regenerative therapy after stroke 21, 22 .
The cellular prion protein (PrP) is enriched in EVs isolated from cerebral spinal fluid (CSF) and in neuronal cells 23, 24 . PrP is a cell surface N-glycosylated, GPI-anchored protein present in detergent-resistant domains (also known as lipid rafts) 25 , which are important for the biogenesis of EVs 26, 27 . Although PrP is highly conserved through evolution and many functions have been suggested, the exact physiological role of PrP is still not well-defined, mainly because knock-out mice for PrP do not present major deficiencies 28, 29 . However, under ischemic conditions, it has been shown that PrP has a protective role. Thus, in mouse models of stroke, PrP C -deficient (PrP-KO) mice present an increased stroke volume compared to wildtype (WT) mice 29, 30 , which can be rescued by PrP overexpression 31, 32 . Moreover, mice overexpressing PrP C showed improved long-term neuronal recovery after stroke, which was associated with increased neuro-and angiogenesis 31 . Interestingly, in mouse models of ischemia, but also in brains from patients suffering from stroke, an increase of PrP has been observed at the penumbra area, probably as an attempt to decrease the oxidative stress [33] [34] [35] . Last but not least, exosomal PrP secreted by astrocytes under ischemic conditions, had a protective effect on ischemic neuronal cerebellar cells, but this protection was eliminated when exosomes were exempt from PrP 36 . PrP undergoes several physiological cleavages that are highly conserved in mammals, including the α-and β-cleavage, and shedding near the GPI anchor, which may account for the myriad of functions attributed to PrP [37] [38] [39] . The fact that α-cleavage, leading to the formation of a released neuroprotective N1 fragment and a membrane-attached C1 fragment, seems to be performed and ensured by several (yet-to-beidentified) proteases, provides an idea of its biological importance 37, 40 .
Because of the potential of EVs in stroke therapy 21, 41 , further understanding and characterization of brain-derived EVs in physiological and under stroke conditions becomes necessary. With this aim, and taking advantage of the recently developed protocols to isolate
EVs from brain 42 , we show here that (i) microglia are the main cell population to release small EVs (≤ 200nm, sEVs) in steady-state conditions; (ii) brain-derived sEVs are enriched in PrP and especially in its truncated C1 fragment, and (iii) this influences the cellular uptake of EVs.
Moreover, (iv) lack of PrP on sEVs increases their uptake by neurons, microglia, and astrocytes. Finally, (v) in a mouse model of stroke, astrocytic contribution to the sEV pool as well as levels of PrP and PrP-C1 on brain sEVs are significantly increased after 24h of reperfusion. We hypothesize that regulating the amounts of PrP, and particularly PrP-C1, is a mechanism to modulate EVs uptake by brain cells and that a deeper understanding of the increased astrocytic release of EVs in reaction to stroke could lead to a targeted therapy.
MATERIAL AND METHODS

Ethics statement
All animal experiments have been conducted after the approval of the local animal care committees (Behörde für Lebensmittelsicherheit und Veterinärwesen Hamburg, project number: N45/2018) and in accordance with the guidelines of the animal facility of the University Medical Center Hamburg-Eppendorf.
Transient Middle Cerebral Artery Occlusion (tMCAO)
The tMCAO was performed as previously described in detail 19 . Three-month-old male mice were used for the procedure. tMCAO was achieved by using a 6-0 nylon monofilament to stop the blood supply for 40 minutes. In the control group ("sham"), animals were also anesthetized, and the arteries were visualized but not disturbed.
Isolation and purification of brain EVs
EVs were isolated from brain as previously described 42 with some modifications. Briefly, frozen brains from C57BL/6 WT or Prnp 0/0 (PrP-KO) mice 43 were gently chopped in few drops of Hibernate-E (Gibco) and transferred to a 15 mL tube containing 75 U/ml of collagenase type III (Worthington) in Hibernate-E at a ratio of 800 μL buffer per 100 mg of brain, and incubated in a water bath at 37°C for 20 min. Alternatively, some samples were incubated with 75U/mL of collagenase type IV (Worthington). During this time, the tube was mixed by inversion every 5 min and pipetted up and down using a 10 mL pipette. Immediately after, the tube was returned on ice and proteinase inhibitors (cOmplete Protease Inhibitor Tablets, Roche) were added. The sample was then centrifuged at 300xg for 5 min at 4°C and the supernatant collected and further centrifuged at 2,000xg for 10 min at 4°C. The supernatant was again collected and centrifuged at 10,000xg for 30 min at 4°C. In order to isolate small extracellular vesicles (sEVs), the supernatant was passed through a 0.22 µm sodium acetate filter (GE Healthcare). The resulting flow-through (filtered) or supernatants that did not pass through the filter (non-filtered) was layered on top of a sucrose gradient (0.6M, 1.3M, 2.5M).
The gradient was centrifuged at 180,000xg for 3 h at 4°C and six fractions of 2 mL each were collected, diluted in PBS, and further centrifuged at 100,000xg at 4°C for 1 h. The final pellet was then resuspended in PBS or RIPA buffer (50mM Tris-HCl pH=7.4, 150mM NaCl, 1% NP40, 0.5% Na-Deoxycholate and 0.1% SDS), containing protease and phosphatase inhibitors (Phospho-Stop Tablets, Roche).
Nanoparticle tracking analysis (NTA)
Resuspended pellets resulting from the 100,000xg centrifugation step were used for NTA.
Briefly, 1 µL of the final pellet suspension were diluted at 1:5,000 for non-filtered EVs and 1:1,000 for filtered EVs in PBS and 500 µL were loaded into the sample chamber of an LM10 unit (Nanosight, Amesbury, UK). Ten videos of ten seconds were recorded for each sample.
Data analysis was performed with NTA 3.0 software (Nanosight). Software settings for analysis were as follows: detection threshold = 6, screen gain = 10.
Fluorescence labelling of exosomes
EVs, in a concentration of 10 12 /ml, were incubated with 8µM of FM-143 (Invitrogen) or with 5nM of mCLING (Synaptic Systems) on ice and in the dark for 5 min. After incubation, the reaction was stopped by adding 1% BSA in PBS. The unincorporated dye was then removed from labelled EVs by centrifugation at 100,000xg at 4°C for 70 min. The final pellet was resuspended in PBS and immediately used for the experiments.
Primary neuronal culture
Primary hippocampal neurons were prepared at P0-P2 as previously described 44 . Briefly, animals were decapitated, the brain was rapidly excised and cleaned from meninges and choroid plexus. Hippocampi were isolated and digested for 30 min at 37°C in 10mM glucose (500 µL/brain) containing 25U of papain (Sigma) and 20 µg/mL DNAse (Sigma). Cells were washed several times with plating medium (MEM, 10mM glucose and 10% horse serum) and, after the last wash, cells were mechanically dissociated. 100,000 cells were plated in 12-well plates containing plating medium and poly-L-lysine-coated 13 mm diameter coverslips. After 5 h, the media was changed to Neurobasal-A medium (Gibco) supplemented with 1% B27
(Thermo Fisher), 0.5% Glutamax (Gibco) and 0.1 % Gentamicin (Gibco). After 24h, arabinoside-C (ARA-C, Tocris) was added in a concentration of 15µM to prevent mitotic, nonneuronal cell proliferation. Neuronal cultures were kept at 37 °C in 5% CO2 for 14 days and half of the medium was replaced every 3 days.
Co-culturing of neurons with an astrocytic feeder layer
For the co-culture, an astrocyte feeder layer was prepared 21 days in advance from P0/P1 mouse pups. Briefly, after isolating the brain and cleaning meninges and choroid plexus, the cortex was removed and put in GGM (Glial Growth Medium: DMEM supplemented with 1.35% glucose, 1% pen/strep and 10% FCS). After addition of pre-warmed 0.25% trypsin, the tissue was digested for 15 min at 37° C in a water bath while shaking (300 rpm). After that, 50 µg/mL of DNAse I was added for 1 minute and the enzymatic reaction was stopped by adding 4 volumes of GMM. Cells were then washed twice with GGM by centrifuging 5 min at 180xg, the cell suspension was passed through a 70 µm cell strainer and the final cell resuspension was plated in T75 flasks with GMM.
For neuronal preparation, P0 mice pups were used as previously described 45 . Briefly, after extracting the brain and cleaning of meninges and choroid plexus, the isolated hippocampi were digested at 37°C for 15 min in dissection media (1x HBSS, 1% pen-strep, 10mM HEPES and 0.6% glucose) containing pre-warmed 0.25% trypsin. After the enzymatic digestion, DNAse I (20 µg/mL) was added and incubated at RT for 1 min. GMM was added to quench the enzymatic reaction. Cells were then centrifuged for 5 min at 180xg. The resulting pellet was gently triturated in Neuronal Maintenance Medium (NMM, Neurobasal medium containing 1% glutamax, 2% B27 and 1% pen-strep) using a 5 mL pipette followed by a 1 mL pipette. Cells were then centrifuged again for 5 min at 180xg. The pellet was resuspended in NMM and passed through a 70 µm cell strainer. About 40,000 cells were plated in 24-well plates containing pre-coated poly-L-lysin coverslips and NMM. After 2 h, the coverslips were inverted on the top of the pre-cultured feeder layer with a wax-dot spacer in between. After 24 h, the mitotic inhibitor FUDR (2′-Deoxy-5-fluorouridine) was added in a concentration of 10µM. Neuronal cultures were kept at 37°C in 5% CO2 for 14 days and half of the medium was replaced every 3 days.
Mixed glia culture
Mixed glia cultures were prepared from P0-P2 mice pups. Briefly, animals were decapitated, the brain excised and cleaned from meninges. The cortex was isolated and washed twice with HBSS (Gibco) containing 10mM HEPES by centrifuging at 310xg for 5 min at 4°C. The tissue was then incubated in digestion solution (HBSS-HEPES 10mM containing 25U of papain and (Gibco)) was added to stop the digestion reaction. Cells were then further centrifuged 5 min at 310xg, the pellet resuspended in the plating media using a Pasteur pipette and passed through a 70 µm strainer. Cells were then plated in T25 Flasks or in 12-well plates. Experiments were repeated 3 times for each time point.
Immunocytochemistry
For STED microscopy, a drop of sEVs, labelled with mCLING as previously described, was placed on a coverslip and then mounted with solid mounting medium (Abberior).
STED and corresponding confocal microscopy were carried out in sequential line scanning mode using an Abberior STED expert line microscope. This setup was based on a Nikon Ti-E microscope body and employed for excitation and detection of the fluorescence signal a 60x
(NA 1.4) P-Apo oil immersion objective. One pulsed laser was used for excitation at 640 nm and near-infrared pulsed laser (775 nm) for depletion. The detected fluorescence signal was directed through a variable-sized pinhole (set to match 1 Airy at 640 nm) and detected by 
Flow cytometry
Mixed culture glia cells were incubated with 5 µL (containing about 2. 
Western blot
The protein amount resulting from the 100.000xg pellet resuspended in RIPA buffer was determined using the Pierce BCA Protein Assay Kit (Thermo Scientific). Samples were then ChemiDoc imaging station (BioRad) and quantified using Image Studio software (LI-COR).
PNGase F assay
For removal of N-linked glycans attached to PrP and its C1 fragment, sEV samples and total homogenates (TH) were digested with PNGase F (New England Biolabs) according to the manufacturer´s protocol.
Electron microscopy
Pellets from the 100.000xg centrifugation were fixed with 4% PFA containing 2.5% 
Statistical analysis
The GraphPad Prism 8 statistic software program was used for the statistical analysis. To assess differences between the THs and the corresponding sEVs and between sEVs from sham and strokes in western blot, after passing a normality test, either a paired or unpaired t-test was used, respectively. Nanosight measurements were assessed by unpaired t-test. Statistical significance was considered when p-values were as follows: *p < 0.05, **p < 0.005, and ***p < 0.001. Values are given as mean ± SEM. The exact p-value is given in the text.
RESULTS
Characterization of brain-derived EVs
Recently, the isolation of EVs from brain has become an important tool to study crucial events in the propagation of misfolded proteins in neurodegenerative diseases 47 . We took GM130 (130 kDa), a resident protein of the cis-Golgi, was used as `proof of no contamination` marker. The total brain homogenate (TH) is shown for comparison. Furthermore, fractions 3 and 4 were pooled and analyzed with transmission electron microscopy (TEM). Non-filtered samples show a combination of small and large vesicles, whereas in filtered samples the population appears more homogeneous (Fig. 1B) . To confirm that the EVs could be visualized by microscopy for further experiments, we labelled them using the mCLING dye, which has the capacity to emit fluorescence only when intercalated in the lipid bilayer but not in the aqueous medium 50 . When isolated EVs were stained, fixed and mounted on coverslips, we compared the signal obtained with confocal microscopy to the one obtained with Stimulated Emission Depletion (STED) microscopy (Fig. 1C) . Due to the higher resolution, the blurred signal obtained with confocal microscopy (in green) was transformed to single dots corresponding to individual EVs in STED (in red), although some aggregates (probably corresponding to clustered EVs) were also present.
Finally, Nanoparticle Tracking Analysis (NTA, Fig. 1D In order to study the relative contribution of different brain cell populations to the whole pool of brain sEVs in physiological conditions, we assessed enrichment of known brain cell typespecific markers in sEVs relative to their signal in TH by western blot analysis ( Fig. 2A) . Each sample signal of the western blot was first referred to the respective signal of the TS as a loading control and then, the mean value obtained in sEVs (n=4) was compared to the mean value obtained in the corresponding TH (n=4). Since it could be that a given marker protein is more sorted into sEVs than others (and thus not directly indicating the relative contribution of this cell population to the total pool of sEVs), we assessed two (exclusively membranebound) protein markers for each cell population in order to reduce the risk of misinterpretation. The G-protein coupled PY2 receptor (P2Y12) and the Transmembrane protein 119 (TMEM119) were chosen as microglial markers 51, 52 ; PLP (proteolipid protein, a major component of the myelin sheet) and 2′-3′-Cyclic nucleotide 3′-phosphodiesterase (CNP)
were used as oligodendrocyte markers 53, 54 ; synapsin 1 and the Synaptosomal NerveAssociated Protein 25 (SNAP25), present at the membrane of synaptic vesicles and at the pre/post-synaptic membrane respectively, were assessed as neuronal markers 55, 56 , and the Excitatory Amino Acid Transporters 1 and 2 (EAAT-1 and EAAT-2) were used as astrocytic markers 57 . Quantifications are shown in Fig. 2B . We observed that, in steady-state conditions, markers for microglia were mainly contributing to the pool of brain sEVs, as P2Y12 (2.5-fold increased; TH set to 100% ±3.9%; sEVs: 247.5 ±12.4%; p=0.0073) and TMEM119 (1.7-fold increased; TH set to 100% ±5.5%; sEVs: 168.7 ±8.6%; p=0.0119) were most drastically enriched in the sEVs fractions compared to the TH. Interestingly, TMEM119 presented a band at around 55 kDa in the TH, whereas in the sEV-enriched fractions, a main band was observed around 20 kDa. Because four isoforms have been described for TMEM119, this lower band could correspond either to a truncated version of TMEM119 or to one of the four isoforms, probably also lacking the O-glycan modification 58 . The oligodendrocyte marker PLP showed a slight yet non-significant increase (TH was set to 100% ±4.7%; sEVs: 138.9% ±11%; p=0.1), whereas the other oligodendrocyte marker CNP1 revealed no differences (TH set to 100% ±15.3%; sEVs:
97.2% ±12.4%). In contrast, the neuronal markers synapsin 1 (syn-1; TH set to 100% ±12.9%; sEVs: 78.1% ±4.9%; p=0.050) and SNAP-25 (TH set to 100% ±3.7%; sEVs: 22.4% ±4.3%; p= 0.0018) were significantly decreased in the sEVs in comparison to the TH , thus implying that neuronal sEVs rather represent a minority in the brain sEV pool under normal conditions.
Lastly, the astrocytic markers EAAT-1 and EAAT-2 showed no differences in sEVs compared to the TH (for EAAT-1: TH set to 100% ±4.6%; sEVs: 95.9% ±6.7%/ for EAAT-2: TH set to 100%
±14.8%; sEVs: 48% ±14.8%), indicating presence but no relative enrichment in the total pool (Fig. 2B) . Thus, neurons and astrocytes only show a moderate contribution to the total sEVs pool in brain, whereas oligodendrocytes and, significantly, microglial sEVS are relatively enriched.
Brain-derived EVs are enriched in PrP and, in particular, its proteolytically truncated C1 fragment
Since we were also interested in PrP as a protein that was shown to act neuroprotective in ischemic insults, and as a known resident of EVs, we performed western blot analyses of filtered and non-filtered EV-enriched fractions. As shown in Fig. 3A , PrP is present in both, medium/large EVs and sEVs. Interestingly, in both cases, the pattern of PrP in EVs is different compared to the TH when visualized with the POM1 antibody that recognizes the C-terminal part of PrP 46 . Hence, for the TH we could observe the typical pattern of PrP with a prominent diglycosylated band at around 43 kDa followed by two lower and less conspicuous bands corresponding to mono-and unglycosylated full-length (fl) PrP. In the EVs fractions, apart from a diglycosylated fl-PrP band, a major band at 34 kDa was present which, as judged by the molecular weight (in our system of pre-cast gels, bands run slightly higher than with other systems), could either represent unglycosylated fl-PrP or its diglycosylated C1 fragment 39 . In order to discriminate between these two forms, we treated the sEVs and the TH fractions with PNGase to enzymatically remove the N-linked glycans (Fig. 3B ). This revealed that the dominant band in the EVs fractions is indeed the C1 fragment of PrP (running at 19 kDa upon deglycosylation). To further prove the identity of this N-terminally truncated C1 fragment, membranes were also developed with the POM2 antibody, recognizing the N-terminal half of PrP 46 . As shown in Suppl. Fig. 1 , after PNGase treatment, only unglycosylated fl-PrP (and a faint band corresponding to diglycosylated fl-PrP due to incomplete deglycosylation) was detectable, whereas the fragment corresponding to PrP-C1 was not visible anymore, thus confirming the identity of PrP-C1 in sEVs. When amounts of PrP in sEVs were compared to the corresponding levels in TH (Fig. 3C, D) , we demonstrate that total levels of PrP are significantly enriched in brain-derived sEVs (PrP in TH set to 100% ±21.8%; sEVs: 195.5% ±14.9%; p= 0.0073). Intriguingly, we found its C1 fragment to be nearly 4-fold increase in sEVs compared to TH (PrP-C1 in TH set to 100% ±13.2%; PrP-C1 in sEVs: 382.7% ±42.5%; p= 0.011; Fig. 3C, D) .
Since the identity of the protease(s) responsible for the α-cleavage of PrP is still unknown 38, 59 , and in order to rule out the possibility that the enrichment in PrP-C1 is an artefact caused by the collagenase III treatment used for sEV isolation, we also isolated sEVs with collagenase IV.
As shown in Suppl. Fig. 2 , the PrP-C1 pattern is similar to samples treated with collagenase III.
Increased release of sEVs by astrocytes and elevated levels of PrP in brain-derived sEVs after tMCAO
To study changes in the relative contribution of different cell populations to the sEV pool in brain at 24 hours after tMCAO, we performed western blot analyses with the brain cell markers described above, comparing sEVs isolated either from shams (n=8) or from tMCAOoperated mice (n=8) (Fig. 4A) . We observed that only the levels of the astrocytic marker EAAT1 were significantly increased in sEVs after tMCAO (shams were set to 100% ±5.6% vs tMCAO, 134.2% ±11.1%; p= 0.0158), probably indicating that at 24 hours after stroke reperfusion injury, there is an increased release of sEVs by astrocytes. Although there was a slight tendency for oligodendrocytic PLP (shams set to 100% ±4.2% vs tMCAO, 158.4% ±34.1) and microglial P2Y12 (shams set to 100% ±4.3% vs tMCAO, 110.8% ±16.8%) to also be increased in sEVs after tMCAO, this was not significant. The neuronal marker synapsin1 was not changed between shams and tMCAO samples (shams set to 100% ±8.7% vs tMCAO, 102% ±10%).
Notably, a significant increase was also seen for total PrP (Fig. 4B) , which was enriched in sEVs from tMCAO samples compared to sham brains (shams set to 100% ±4.4% versus strokes:
121.47.6%; p=0.0284). When diglycosylated fl-PrP (di-fl-PrP) and the PrP-C1 bands were quantified individually, we observed that both were significantly increased in sEVs after tMCAO (for PrP-C1: shams set to 100% ±5.2% versus strokes: 124.9% ±9.6%; p= 0.039/for di fl-PrP: shams set to 100% ±6.6% versus strokes: 131.3% ±5.2; p= 0.0024).
PrP influences uptake of brain-derived EVs by primary neurons and glia cells
We have demonstrated that PrP in brain-derived EVs is highly enriched in the C1 fragment.
This fragment, resulting from the α-cleavage in the middle of the PrP sequence, exposes a hydrophobic domain at its N-terminus 39 . Both, the structural aspect with a stretch of hydrophobic amino acids and its dependence on proteolytic "activation" are strikingly reminiscent of some viral surface glycoproteins critical for host cell attachment and membrane fusion (for instance those of some paramyxoviruses). In these viruses, the viral envelope fuses with the host cell membrane with the help of two glycoproteins, one that initially attaches the virus and another one that, after an endoproteolytic cleavage, exposes the highly hydrophobic fusion peptide, which integrates into the host cell membrane and mediates the fusion process 60, 61 . Because of the above-mentioned similarities between PrP-C1 and the fusogenic viral surface proteins, and given the enrichment of PrP-C1 in the EVs membrane, we hypothesized that the C1 fragment might act as a tethering factor and play a role in the uptake of EVs by cells 39 . To assess the role of PrP in EVs, we incubated primary neuronal cultures from WT mice with labeled sEVs isolated from either WT or PrP-KO mouse brain and fixed them after 1, 3 or 6 hours of incubation. As shown in Fig. 5A , after 1h of incubation, labeled sEVs from WT (shown in white) presented as a rather diffuse staining surrounding the neuronal cell body (marked by phalloidin staining in green), whereas the PrP-KO-sEVs showed a dotty staining at the plasma membrane, and with some of them having already been internalized at this early time point. Surprisingly, we also observed that our primary cultures contained some microglia, despite having been treated with Arabinoside C to eradicate proliferating cells. In several instances, these microglia were found to contain high amounts of PrP-KO-derived sEVs, a feature that we could not observe for WT-derived sEVs (Fig. 5A, Fig 6A) . We then established another protocol for primary neuronal cultures from WT mice (low-density culture, LDC), where neurons grow in co-culture with (yet spatially separated from) astrocytes 45 . On the one hand, this approach allows for lower seeding density and, therefore, improved microscopic analysis, while on the other hand, contamination by other brain cell types is sensibly lower. As shown in Fig. 5B , we could again confirm a strong difference in the neuronal uptake behaviour, with PrP-KO-derived sEVs being efficiently taken up in contrast to sEVs from WT brain (which at 1h of incubation were hardly detectable in the culture). Moreover, although microglia were much less and therefore more difficult to find in this type of culture, the few microglia cells that could be identified were also highly decorated with PrP-KO-sEVs, whereas microglia showed less positive EV-associated labelling when treated with WT-derived sEVs. The quantification in Fig. 5C shows that the neuronal uptake in the primary culture with higher amounts of microglia (HDC) was almost twofold increased for the PrP-KO-derived sEVs than for WT-derived sEVs (WT-sEVs: set to 100% ±5.3%; PrP-KOsEVs: 185.8% ±12.5%; p≤0.0001), whereas in the LDC, with low microglia content, neuronal uptake of sEVs from PrP-KO brain was about three times higher compared to WT-sEVs (WTsEVs: set to 100% ±8.6%; PrP-KO-sEVs: 323.3% ±22.1%; p≤0.0001). We hypothesize that this difference between the culture conditions could either be a consequence of the lower number of neurons or the reduction in microglia in the LDC, both resulting in a higher sEV-toneuron ratio. In order to confirm that microglia were taking up high amounts of PrP-KO-sEVs, we established a mixed glial cell cultures (mainly containing microglia and astrocytes) and incubated them with either WT-sEVs or PrP-KO-sEVs for 3h. This type of culture allowed us to measure the sEVs uptake not only by microglia but also by astrocytes (which were absent in our previous primary neuronal cultures). After incubation with sEVs we labelled the two populations with cell specific markers (GLAST-1 for astrocytes and CD11b for microglia) and performed flow cytometric analysis. As shown in Fig. 6B , we could confirm that microglia take up more PrP-KO-sEVs than WT-sEVs (WT-sEVs set to 100% ±2.5% vs PrP-KO-sEVs: 163.2%
±22.3%; p=0.035). Therefore, as observed for neurons and microglia at 1h, PrP-KO-sEVS were also taken up more efficiently by astrocytes (WT-sEVs set to 100% ±2.6% vs PrP-KO-sEVs:
166.9% ±16.6%; p=0.0068).
Regarding the neuronal uptake at 3h (Fig. 7A) , treatment with WT-sEVs in the HDC again revealed a diffuse staining of the sEV-labeling at the plasma membrane, although seemingly more intense than after 1h (Fig. 5A ). In addition, some sEVs could now be detected as vesiclelike structures at the plasma membrane or even internalized and colocalizing with the lysosomal marker LAMP-1, lysosomes being described as one of the major targets of internalized EVs 62, 63 . In the case of PrP-KO-sEVs, although some signal was still detected at the plasma membrane, the majority at this time point was observed inside the neurons and colocalizing with LAMP-1. Quantification of sEVs signal intensity inside neurons (Fig. 7C) showed that at 3h still about the double amount of PrP-KO-sEVs was taken up compared to WT-sEVs (WT-sEVs set to 100% ±7.45% vs PrP-KO-sEVs: 219% ±16.3%; p≤0.0001).
At the latest time point assessed in this study (6h of incubation), the vast majority of both, WT-and PrP-KO-sEVs, were found inside neurons and colocalizing with LAMP-1 (Fig. 7B) .
Again, quantification of the sEVs-associated fluorescence signal present inside the neurons still revealed a higher amount of uptaken sEVs from PrP-KO compared to those derived from WT brain (WT-sEVs set to 100% ±6.6% vs PrP-KO-sEVs: 145.37% ±8.56%; p≤0.0001). For the LDC system (Suppl. Fig. 3 ), results obtained at 3h and 6h were similar to the ones mentioned above(for 3h incubation: WT-sEVs set to 100% ±3.46% vs PrP-KO-sEVs: 214% ±17.58%;
p≤0.0001/for 6h incubation: WT-sEVs set to 100% ±5.6% vs PrP-KO-sEVs: 187% ±14%;
p≤0.0001). In contrast to the 1h incubation (Fig. 5) , the absence of differences between the two culture systems at these time points can probably be explained by the fact that there were no more free sEVs present in the media.
DISCUSSION
In the present study, we have characterized sEVs in the murine brain in steady-state conditions and after 24h of stroke reperfusion. We show that, under physiological conditions, microglia are the main sEVs source in brain. This situation changes at 24h after induced stroke-reperfusion, where a significant increase of astrocytic sEVs was observed.
Furthermore, we show that brain-derived sEVs are enriched in PrP, and particularly in its C1 fragment, with consequences in the regulation of vesicle uptake by recipient cells. Thus, when sEVs lack PrP, their uptake by neurons is increased and, conspicuously, they are also more readily taken up by microglia and astrocytes. We also demonstrate that, 24 hours after stroke, the amount of PrP (and PrP-C1) in the brain sEVs pool is significantly increased, which may have functional consequences in intercellular communication after stroke (a graphical summary of the principal findings is depicted in Fig. 8 ).
EVs have become an intense field of research, not only because they represent a novel form of cell-to-cell communication able to bridge wide distances, but also by their potential applicability as therapeutic tools. In the case of brain disorders, they are very attractive because of their property to cross the BBB when genetically modified to target the brain 64 . A protective role of EVs derived from mesenchymal cells in a variety of brain insults and disorders 65 , including stroke [66] [67] [68] [69] , has also been shown. Until recently, most of the EVs assessed in various studies were isolated from cell culture supernatants or body fluids, but the isolation of EVs from complex tissue such as the brain parenchyma has been increasingly reported only in the last few years 42, 70, 71 .
Despite enormous progress in recent years, the isolation and characterization of EVs are still a challenge, which is mainly due to their size. One of the aims of our study was to characterize the differential contribution of the brain cell populations to the EVs pool in normal conditions and to assess potential changes after 24 hours of ischemia-reperfusion in the tMCAO mouse model of stroke. We modified a protocol of EVs isolation from brain 42 by including a filtration step in order to differentiate between small EVs (≤200 nm) and medium/large EVs (≥ 200nm).
We performed this step to yield a homogeneous population for our downstream analyses. As assessed by EM and NTA, we could observe that, without this additional filtration step, there is a heterogeneous population of brain EVs. Based on size measurements and the presence of Alix, a resident protein of MVBs, we think that our brain-derived sEVs represent a mixture of bona fide exosomes and small microvesicles 48 .
Intuitively, it may seem reasonable that exosomes (released upon fusion of MVBs with the plasma membrane) and microvesicles (generated by "budding" from the plasma membrane) are released upon different stimuli and that some cell types are probably more prone to release one type over the other. However, it is not known whether this scenario is really the case.
Because the cargo of EVs is cell type-dependent and includes proteins that reflect their cellular origin, we sought to investigate the relative contribution of different cell types to the brain sEVs pool by assessing the relative enrichment (compared to TH) of certain brain cell markers by western blot. We show that, in steady-state conditions, P2Y12 and TMEM-119, two known markers of microglia, are significantly enriched in the pool of sEVs of mouse brain.
On the contrary, the neuronal markers synapsin and SNAP-25 showed a significant relative decrease, indicating a poor contribution to the total sEVs brain pool. Oligodendrocytes (labelled with PLP and CNP1) and astrocytes ( with EAAT-1 and EAAT-2 as exclusive markers), showed no enrichment in sEVs when compared to the TH, and therefore, we concluded they are not the major populations that contribute to the brain sEVs pool in steady-state conditions. We cannot rule out the possibility that certain proteins are more heavily packed into EVs than others, but the use of two markers for each cell type and the fact they were behaving similarly, reduces the risk of misinterpretation and ensures more reliable results regarding the relative contribution of different cells. Relative quantification of EVs in brain is not an easy issue. In a recent paper, Silverman et al. 72 have also characterized the relative proportion of EVs derived from different brain cell populations. By means of flow cytometry and in contrast to our findings, they observed an increased proportion of astrocytic and neuronal markers in both, brain and in spinal cord samples. The discrepancy with our results could be a consequence of (i) investigation of different subpopulations of EVs (note that we included a 0.2 µm filter step) and (ii) the detection limit of the flow cytometry possibly excluding some small vesicles that were considered as debris (which are included in the western blot analyses of our study). It has been calculated that sEVs are at least one order of magnitude more frequent than medium/large EVs 73, 74 and this pool may have been lost by flow cytometry measurements.
What we observed under the same settings is that, 24 after stroke reperfusion, brain sEV landscape was changing as sEVs containing the astrocytic marker EAAT-1 were significantly increased. Astrocytes have a myriad of important functions in the brain, ranging from regulation of synaptic transmission, modulation of neuronal excitability, BBB formation, and regulation of blood flow. Since they are relatively resistant to glucose and oxygen deprivation, they cope better than neurons with ischemic insults and, at present, they are raising attention as potential targets in stroke therapy 75 . At earlier times points after ischemia, astrocytes proliferate, become hypertrophic (reactive astrogliosis) and, after a few days, start to form the glial scar with both, potential benefits but also detrimental effects 76 . It has been shown that astrocytes start proliferating from one day after injury 77 . Likewise, microglia are significantly increased at 24h in a mouse model of stroke 19 . Since there is close communication between astrocytes and microglia after injury, and given that activated astrocytes can in turn contribute to the activation of distant microglia after ischemia 78 , it may be that the release of EVs from astrocytes at 24h is a factor facilitating the spread of reactive microglia. Moreover, astrocytes present neuroprotective features after stroke 79 and neurons exposed to reactive oxygen species (ROS) showed increased survival when treated with astrocytic EVs 80 . Whether the relative increase in astrocytic sEVs is related to microglia proliferation, the formation of the glial scar, or for protection against ROS, clearly deserves further studies. Interestingly, Guitart et al. 36 showed that exosomes released by astrocytes under hypoxic conditions (using the in vitro model of oxygen-glucose deprivation, OGD) conferred protection to neurons. Of note, this activity was dependent on the presence of PrP, which they found increased in exosomes derived from stressed astrocytes. Contrarily, exosomes from stressed astrocytes devoid of PrP were not protective. In our experiments, apart from the increase of sEVs released by astrocytes, we also observed an increase of sEVassociated PrP levels after stroke. Due to technical limitations, we could not assess whether this upregulation is caused by the relative increase of astrocytic sEVs. However, in view of the reported neuroprotective effects of PrP after ischemia 30, 35 Doeppner, 2015 #933 , this increase in both, astrocytic sEVs and sEV-associated PrP amounts, could represent a protective feedback mechanism to counteract the oxidative stress present in the first hours after stroke. Although an increase in PrP levels has been observed in animal models of stroke and in humans after ischemic insult 33, [81] [82] [83] , the present study is the first to report elevated levels of this protein in brain-derived sEVs. However, further studies are clearly required to elucidate its
consequences.
We also demonstrate that, in steady-state, the proteolytically generated PrP-C1 fragment is particularly enriched in brain sEVs. Vella et al. 84 already found that PrP present in EVs could not be recognized with antibodies against the N-terminal part of the protein, indicating truncation. In support of that study, we show here that the main PrP forms packed onto sEVs in the brain are PrP-C1 together with fl-PrP (with both largely being diglycosylated). We had already suggested a parallelism between the hydrophobic domain, which is N-terminally exposed in C1 after the α-cleavage of PrP, and the fusion peptide of certain viral surface proteins 39 . Because the latter allows viruses to dock to and fuse with the host cells, we hypothesized that PrP-C1 on EVs could perform a similar function, such as tethering EVs to recipient cells and/or facilitating their uptake. The fact that EVs also share many similarities with viruses 85, 86 would reinforce our hypothesis. Surprisingly, we found that, as early as one hour of incubation, brain sEVs lacking PrP are readily taken up and present inside neurons (and glia cells), whereas sEVs from WT mice are not taken up at this time-point, but are rather present as diffuse staining surrounding the neuronal body. At later time points, although WTsEVs are taken up and start to colocalize with lysosomes, there are still significant differences compared with PrP-KO sEVs, with the latter being massively taken up and colocalizing with lysosomes 87 . This seems counterintuitive with our initial hypothesis since our findings rather indicate that a lack of PrP leads to more efficient uptake. However, it has been shown that EVs can either fuse with the plasma membrane, thereby releasing their content into the cytoplasm, or they can be taken up by clathrin/caveolin-dependent mechanisms or by phagocytosis and macropinocytosis 88 . Since we always incubated the same amount of sEVs but consistently detected more endocytosed PrP-KO sEVs, this could indicate that presence of PrP and/or PrP-C1 (in WT-sEVs) indeed influences fusions events. This may also be supported by the diffuse sEV-associated staining at the plasma membrane found at 1h and 3h for WT-sEVs. In contrast, in the absence of PrP, it seems that vesicles are taken up more quickly by other mechanisms and delivered to organelles (i.e. lysosomes). Thus, modulation of PrP composition could regulate EV fusion versus uptake and, consequently, influence whether EV cargo is released to the cytoplasm or intracellular compartments, respectively. It has been reported that fusion between EVs and plasma membrane in a cell-free system requires the presence of proteins at the surface of both entities and an acidic pH 89 . Given that, at a later time-point, we observed both WT-and PrP-KO-sEVs to colocalize with LAMP-1, final lysosomal targeting of sEVs seems to be PrP-independent. In general, intracellular cargo delivery of EVs is still poorly understood and further studies, as for the potential role of PrP in these processes, are clearly needed to clarify this important point in EV biology.
Interestingly, the uptake of sEVs lacking PrP by microglia and by astrocytes was likewise highly increased. This result could point out to a role of PrP in EV recognition by the immune system.
It is striking that PrP is highly abundant in organs that possess immunological privilege, such as brain, placenta, and testicles 90 . Fittingly, in several inflammatory processes, such as ischemia, brain trauma, and EAE, the inflammatory damage is exacerbated when PrP is absent, suggesting a role in immune quiescence 90 .
In conclusion, the present study describes that microglia are the main contributors to the sEV 
